| BRCA AHS - M2003 “Notification” |
Reviewed by Avalon 1st Quarter 2021 CAB. Medical Director review 4/2021. Under “When Not Covered” section added two non-covered indications: c. Women diagnosed with breast cancer at age >65 years, with no close relative with breast, ovarian, pancreatic, or prostate cancer as there is a low probability that testing will have findings of documented clinical utility; d. Men diagnosed with localized prostate cancer with Gleason Score <7 and no close relative with breast, ovarian, pancreatic, or prostate cancer as there is a low probability that testing will have findings of documented clinical utility. Clarified items in “When Covered” section with no content changes. Updated Policy Guidelines section as well as References. Under Description section added related policy AHS-M2066 Genetic Cancer Susceptibility Using Next Generation Sequencing. Reordered and clarified *Notes 1-5. Notification 5/4/21 for effective date 7/13/21. |
Blue Connect